These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29772485)

  • 1. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
    Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
    Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
    Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cognitive dysfunction between schizophrenia and bipolar disorder patients: A meta-analysis of comparative studies.
    Li W; Zhou FC; Zhang L; Ng CH; Ungvari GS; Li J; Xiang YT
    J Affect Disord; 2020 Sep; 274():652-661. PubMed ID: 32663999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in cognitive function in early psychosis: a meta-analysis with the MATRICS consensus cognitive battery (MCCB).
    Ding Y; Hou W; Wang C; Sha S; Dong F; Li X; Wang N; Lam ST; Zhou F; Wang C
    Schizophr Res; 2024 Aug; 270():349-357. PubMed ID: 38968806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis.
    Zhang T; Yi Z; Li H; Cui H; Tang Y; Lu X; Xu L; Qian Z; Zhu Y; Jiang L; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):71-8. PubMed ID: 26189033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
    Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social cognitive functioning in prodromal psychosis: A meta-analysis.
    Lee TY; Hong SB; Shin NY; Kwon JS
    Schizophr Res; 2015 May; 164(1-3):28-34. PubMed ID: 25749019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
    Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
    PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment profile in adolescent early-onset psychosis using the MATRICS Battery: Age and sex effects.
    Smelror RE; Johannessen C; Wedervang-Resell K; Jørgensen KN; Barth C; Andreou D; Ueland T; Andreassen OA; Myhre AM; Rund BR; Agartz I
    Neuropsychology; 2021 Mar; 35(3):300-309. PubMed ID: 33970663
    [No Abstract]   [Full Text] [Related]  

  • 16. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.
    Catalan A; Radua J; McCutcheon R; Aymerich C; Pedruzo B; González-Torres MÁ; Baldwin H; Stone WS; Giuliano AJ; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2022 May; 12(1):198. PubMed ID: 35551176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
    Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
    Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Bonivento C; Kambeitz-Ilankovic L; Maggioni E; Borgwardt S; Lencer R; Meisenzahl E; Kambeitz J; Ruhrmann S; Salokangas RKR; Bertolino A; Stainton A; Wenzel J; Pantelis C; Wood SJ; Upthegrove R; Koutsouleris N; Brambilla P;
    Br J Psychiatry; 2023 Oct; 223(4):485-492. PubMed ID: 37846967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis.
    Cai B; Zhu Y; Liu D; Li Y; Bueber M; Yang X; Luo G; Su Y; Grivel MM; Yang LH; Qian M; Stone WS; Phillips MR
    Lancet Reg Health West Pac; 2024 Apr; 45():101016. PubMed ID: 38699289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.